N-((3,5-DIFLUORO-3'-(1H-1,2,4-TRIAZOL-3-YL)-4-BIPHENYLYL)METHYL(-2,3-DIHYDRO-1H-INDEN-2-AMINE

Name: N-((3,5-DIFLUORO-3'-(1H-1,2,4-TRIAZOL-3-YL)-4-BIPHENYLYL)METHYL(-2,3-DIHYDRO-1H-INDEN-2-AMINE in Obesity
Creator: Floatz
License: https://terminal.floatz.ai/terms

Obesity

GlaxoSmithKlineSmall moleculePhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 49/ 100
Competitive Position: 59/ 100

Competitive context

575 Active assets in the Obesity cohort.

Asset / Sponsor	Phase	Rating
vi-0521 VIVUS LLC	Phase 4	BBB
Tirzepatide LABORATORIOS INDUFAR	Phase 4	BBB
Efsubaglutide Alfa The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Phase 4	BBB
Phentermine Russell McCulloh, MD	Phase 4	BBB
Deoxycholic Acid University of California, San Diego	Phase 4	BBB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →